{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:03:22Z","timestamp":1788926602352,"version":"build-2803163510"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Interleukin 33 (IL-33) is a crucial inflammatory factor that functions as an alarm signal in endometriosis (EMs). Epithelial-mesenchymal transition (EMT), a process related to inflammatory signals, intracellular reactive oxygen species (ROS) production, and lipid peroxidation, have been proposed as potential mechanisms that contribute to the development and progression of EMs. IL-33 is highly upregulated in the ectopic milieu. Moreover, ectopic endometrial cells constitutively express interleukin-33 receptor ST2 (IL-33R). However, the role of IL-33\/ST2 in the EMT of EMs remains largely unknown. In this study, we aimed to mechanistically determine the role of IL-33\/ST2 in EMs-associated fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We established a non-lethal oxidative stress model to explore the conditions that trigger IL-33 induction. We performed \u03b1-smooth muscle actin (\u03b1-SMA) protein detection, cell counting kit-8 (CCK-8) assays, and scratch assays to analyze the impact of IL-33 on primary endometrial stromal cells (ESCs) proliferation and invasion. Clinical samples from patients with or without EMs were subjected to immunohistochemical (IHC) and and immunofluorescence(IF) staining to assess the clinical relevance of IL-33 receptor ST2 and EMT-related proteins. Furthermore, we used the ectopic human endometrial epithelial cell line 12Z and normal human epithelial cell line EEC to evaluate the effects of IL-33 on Wnt\/\u03b2-catenin signaling. The effect of IL-33 on EMT-associated fibrosis was validated in vivo by intraperitoneal injections of IL-33 and antiST2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed that ectopic milieu, characterized by ROS, TGF-\u03b21, and high level of estrogen, triggers the secretion of IL-33 from ectopic ESCs. Ectopic endometrial lesions exhibited higher level of fibrotic characteristics and ST2 expression than that in the normal endometrium. Exogenous recombinant human (rhIL-33) enhanced ESC migration and survival. Similarly, 12Z cells displayed a higher degree of EMT characteristics with elevated expression of CCN4 and Fra-1, downstream target genes of the WNT\/\u03b2-catenin pathway, than that observed in EECs. Conversely, blocking IL-33 with neutralizing antibodies, knocking down ST2 or \u03b2-catenin with siRNA, and \u03b2-catenin dephosphorylation abolished its effects on EMT promotion. In vivo validation demonstrated that IL-33 significantly promotes EMs-related fibrosis through the activation of Wnt\/\u03b2-catenin signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data strongly support the vital role of the IL-33\/ST2 pathway in EMs-associated fibrosis and emphasize the importance of the EMT in the pathophysiology of fibrosis. Targeting the IL-33\/ST2\/Wnt\/\u03b2-catenin axis may hold promise as a feasible therapeutic approach for controlling fibrosis in EMs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-024-01683-x","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:02:01Z","timestamp":1717977721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The IL-33-ST2 axis plays a vital role in endometriosis via promoting epithelial\u2013mesenchymal transition by phosphorylating \u03b2-catenin"],"prefix":"10.1186","volume":"22","author":[{"given":"Jingyao","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzhi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaikai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,10]]},"reference":[{"issue":"11","key":"1683_CR1","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.cell.2021.04.041","volume":"184","author":"PTK Saunders","year":"2021","unstructured":"Saunders PTK, Horne AW. Endometriosis: etiology, pathobiology, and therapeutic prospects. Cell. 2021;184(11):2807\u201324.","journal-title":"Cell"},{"issue":"13","key":"1683_CR2","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1056\/NEJMra1810764","volume":"382","author":"KT Zondervan","year":"2020","unstructured":"Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244\u201356.","journal-title":"N Engl J Med"},{"issue":"8","key":"1683_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3390\/diagnostics11081434","volume":"11","author":"B Doroftei","year":"2021","unstructured":"Doroftei B, Ilie OD, Balmus IM, Ciobica A, Maftei R, Scripcariu I, Simionescu G, Grab D, Stoian I, Ilea C. Molecular and clinical insights on the complex interaction between oxidative stress, apoptosis, and Endobiota in the pathogenesis of endometriosis. Diagnostics (Basel). 2021;11(8):1434.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"1683_CR4","first-page":"479","volume":"15","author":"Y Song","year":"2018","unstructured":"Song Y, Liu J, Qiu Z, Chen D, Luo C, Liu X, Hua R, Zhu X, Lin Y, Li L, et al. Advanced oxidation protein products from the follicular microenvironment and their role in infertile women with endometriosis. Exp Ther Med. 2018;15(1):479\u201386.","journal-title":"Exp Ther Med"},{"key":"1683_CR5","doi-asserted-by":"publisher","first-page":"117727271668981","DOI":"10.1177\/1177272716689818","volume":"9","author":"H Winarto","year":"2017","unstructured":"Winarto H, Tan MI, Sadikin M, Wanandi SI. ARID1A expression is down-regulated by oxidative stress in endometriosis and endometriosis-associated ovarian cancer. Transl Oncogenomics. 2017;9:1177272716689818.","journal-title":"Transl Oncogenomics"},{"key":"1683_CR6","doi-asserted-by":"publisher","first-page":"794997","DOI":"10.3389\/fphar.2021.794997","volume":"12","author":"C Estornut","year":"2021","unstructured":"Estornut C, Milara J, Bayarri MA, Belhadj N, Cortijo J. Targeting oxidative stress as a therapeutic approach for idiopathic pulmonary fibrosis. Front Pharmacol. 2021;12:794997.","journal-title":"Front Pharmacol"},{"issue":"9","key":"1683_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/17474124.2021.1949289","volume":"15","author":"S Seen","year":"2021","unstructured":"Seen S. Chronic liver disease and oxidative stress - a narrative review. Expert Rev Gastroenterol Hepatol. 2021;15(9):1021\u201335.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"1683_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3390\/antiox10060931","volume":"10","author":"AK Shah","year":"2021","unstructured":"Shah AK, Bhullar SK, Elimban V, Dhalla NS. Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure. Antioxidants (Basel). 2021;10(6):931.","journal-title":"Antioxidants (Basel)"},{"key":"1683_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3389\/fimmu.2019.00522","volume":"10","author":"F Alvarez","year":"2019","unstructured":"Alvarez F, Fritz JH, Piccirillo CA. Pleiotropic effects of IL-33 on CD4(+) T cell differentiation and effector functions. Front Immunol. 2019;10:522.","journal-title":"Front Immunol"},{"issue":"22","key":"1683_CR10","doi-asserted-by":"publisher","first-page":"9021","DOI":"10.1073\/pnas.0812690106","volume":"106","author":"C Cayrol","year":"2009","unstructured":"Cayrol C, Girard JP. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A. 2009;106(22):9021\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1683_CR11","doi-asserted-by":"publisher","first-page":"155891","DOI":"10.1016\/j.cyto.2022.155891","volume":"156","author":"C Cayrol","year":"2022","unstructured":"Cayrol C, Girard JP. Interleukin-33 (IL-33): a critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine. Cytokine. 2022;156:155891.","journal-title":"Cytokine"},{"key":"1683_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","volume":"31","author":"C Cayrol","year":"2014","unstructured":"Cayrol C, Girard JP. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014;31:31\u20137.","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"1683_CR13","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/all.13158","volume":"72","author":"M Uchida","year":"2017","unstructured":"Uchida M, Anderson EL, Squillace DL, Patil N, Maniak PJ, Iijima K, Kita H, O\u2019Grady SM. Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium. Allergy. 2017;72(10):1521\u201331.","journal-title":"Allergy"},{"key":"1683_CR14","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.3389\/fimmu.2018.02432","volume":"9","author":"OS Kotsiou","year":"2018","unstructured":"Kotsiou OS, Gourgoulianis KI, Zarogiannis SG. IL-33\/ST2 axis in organ fibrosis. Front Immunol. 2018;9:2432.","journal-title":"Front Immunol"},{"issue":"6","key":"1683_CR15","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.7150\/thno.51648","volume":"11","author":"WY Chen","year":"2021","unstructured":"Chen WY, Wu YH, Tsai TH, Li RF, Lai AC, Li LC, Yang JL, Chang YJ. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis. Theranostics. 2021;11(6):2594\u2013611.","journal-title":"Theranostics"},{"issue":"7","key":"1683_CR16","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/humrep\/des154","volume":"27","author":"P Santulli","year":"2012","unstructured":"Santulli P, Borghese B, Chouzenoux S, Vaiman D, Borderie D, Streuli I, Goffinet F, de Ziegler D, Weill B, Batteux F, et al. Serum and peritoneal interleukin-33 levels are elevated in deeply infiltrating endometriosis. Hum Reprod. 2012;27(7):2001\u20139.","journal-title":"Hum Reprod"},{"issue":"1","key":"1683_CR17","doi-asserted-by":"publisher","first-page":"17903","DOI":"10.1038\/s41598-017-18224-x","volume":"7","author":"JE Miller","year":"2017","unstructured":"Miller JE, Monsanto SP, Ahn SH, Khalaj K, Fazleabas AT, Young SL, Lessey BA, Koti M, Tayade C. Interleukin-33 modulates inflammation in endometriosis. Sci Rep. 2017;7(1):17903.","journal-title":"Sci Rep"},{"key":"1683_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jri.2018.07.006","volume":"130","author":"A Jaeger-Lansky","year":"2018","unstructured":"Jaeger-Lansky A, Schmidthaler K, Kuessel L, Gstottner M, Waidhofer-Sollner P, Zlabinger GJ, Wenzl R, Eiwegger T. Local and systemic levels of cytokines and danger signals in endometriosis-affected women. J Reprod Immunol. 2018;130:7\u201310.","journal-title":"J Reprod Immunol"},{"issue":"23","key":"1683_CR19","doi-asserted-by":"publisher","first-page":"e149699","DOI":"10.1172\/jci.insight.149699","volume":"6","author":"JE Miller","year":"2021","unstructured":"Miller JE, Lingegowda H, Symons LK, Bougie O, Young SL, Lessey BA, Koti M, Tayade C. IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis. JCI Insight. 2021;6(23):e149699.","journal-title":"JCI Insight"},{"issue":"3","key":"1683_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s43032-019-00090-9","volume":"27","author":"Y Ono","year":"2020","unstructured":"Ono Y, Yoshino O, Hiraoka T, Akiyama I, Sato E, Ito M, Kobayashi M, Nakashima A, Wada S, Onda T, et al. IL-33 exacerbates Endometriotic lesions via polarizing peritoneal macrophages to M2 subtype. Reprod Sci. 2020;27(3):869\u201376.","journal-title":"Reprod Sci"},{"issue":"4","key":"1683_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.tjog.2021.05.013","volume":"60","author":"TC Lin","year":"2021","unstructured":"Lin TC, Wang KH, Chuang KH, Kao AP, Kuo TC. Interleukin-33 promotes invasiveness of human ovarian endometriotic stromal cells through the ST2\/MAPK\/MMP-9 pathway activated by 17beta-estradiol. Taiwan J Obstet Gynecol. 2021;60(4):658\u201364.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1683_CR22","doi-asserted-by":"crossref","unstructured":"Hadpech S, Thongboonkerd V. Epithelial-mesenchymal plasticity in kidney fibrosis. Genesis. 2024;62(1):e23529.","DOI":"10.1002\/dvg.23529"},{"issue":"12","key":"1683_CR23","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/ijms21124271","volume":"21","author":"DY Shu","year":"2020","unstructured":"Shu DY, Butcher E, Saint-Geniez M. EMT and EndMT: emerging roles in age-related macular degeneration. Int J Mol Sci. 2020;21(12):4271.","journal-title":"Int J Mol Sci"},{"key":"1683_CR24","doi-asserted-by":"publisher","first-page":"937988","DOI":"10.3389\/fphys.2022.937988","volume":"13","author":"T Lih Yuan","year":"2022","unstructured":"Lih Yuan T, Sulaiman N, Nur Azurah AG, Maarof M, Rabiatul Adawiyah R, Yazid MD. Oestrogen-induced epithelial-mesenchymal transition (EMT) in endometriosis: Aetiology of vaginal agenesis in Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome. Front Physiol. 2022;13:937988.","journal-title":"Front Physiol"},{"issue":"4","key":"1683_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s00404-013-3040-4","volume":"289","author":"J Bartley","year":"2013","unstructured":"Bartley J, J\u00fclicher A, Hotz B, Mechsner S, Hotz H. Epithelial to mesenchymal transition (EMT) seems to be regulated differently in endometriosis and the endometrium. Arch Gynecol Obstet. 2013;289(4):871\u201381.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"1683_CR26","doi-asserted-by":"publisher","first-page":"e2666","DOI":"10.1038\/cddis.2017.95","volume":"8","author":"KK Chang","year":"2017","unstructured":"Chang KK, Liu LB, Jin LP, Zhang B, Mei J, Li H, Wei CY, Zhou WJ, Zhu XY, Shao J, et al. IL-27 triggers IL-10 production in Th17 cells via a c-Maf\/ROR\u03b3t\/Blimp-1 signal to promote the progression of endometriosis. Cell Death Dis. 2017;8(3):e2666.","journal-title":"Cell Death Dis"},{"issue":"10","key":"1683_CR27","doi-asserted-by":"publisher","first-page":"e1436","DOI":"10.1038\/cddis.2014.414","volume":"5","author":"MQ Li","year":"2014","unstructured":"Li MQ, Wang Y, Chang KK, Meng YH, Liu LB, Mei J, Wang Y, Wang XQ, Jin LP, Li DJ. CD4+Foxp3+ regulatory T cell differentiation mediated by endometrial stromal cell-derived TECK promotes the growth and invasion of endometriotic lesions. Cell Death Dis. 2014;5(10):e1436.","journal-title":"Cell Death Dis"},{"key":"1683_CR28","doi-asserted-by":"publisher","first-page":"1133672","DOI":"10.3389\/fimmu.2023.1133672","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen Y, Xiao Y, Ruan J, Tian Q, Cheng Q, Chang K, Yi X. Distinct subtypes of endometriosis identified based on stromal-immune microenvironment and gene expression: implications for hormone therapy. Front Immunol. 2023;14:1133672.","journal-title":"Front Immunol"},{"issue":"6","key":"1683_CR29","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","volume":"117","author":"S Sanada","year":"2007","unstructured":"Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 2007;117(6):1538\u201349.","journal-title":"J Clin Invest"},{"issue":"7","key":"1683_CR30","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/all.15762","volume":"78","author":"K Saito","year":"2023","unstructured":"Saito K, Orimo K, Kubo T, Tamari M, Yamada A, Motomura K, Sugiyama H, Matsuoka R, Nagano N, Hayashi Y, et al. Laundry detergents and surfactants-induced eosinophilic airway inflammation by increasing IL-33 expression and activating ILC2s. Allergy. 2023;78(7):1878\u201392.","journal-title":"Allergy"},{"key":"1683_CR31","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1007\/s43032-023-01315-8","volume":"30","author":"L Wu","year":"2023","unstructured":"Wu L, Huang X, Wang R, Li Y, Zhu H, Ouyang Y, Huang W. Increased expression of TGF-beta1 contributes to the downregulation of progesterone receptor expression in the Eutopic endometrium of infertile women with minimal\/mild endometriosis. Reprod Sci. 2023;30:3578\u201389.","journal-title":"Reprod Sci"},{"key":"1683_CR32","doi-asserted-by":"publisher","first-page":"1034614","DOI":"10.3389\/fendo.2022.1034614","volume":"13","author":"JP Emond","year":"2022","unstructured":"Emond JP, Caron P, Pusic M, Turcotte V, Simonyan D, Vogler A, Osredkar J, Rizner TL, Guillemette C. Circulating estradiol and its biologically active metabolites in endometriosis and in relation to pain symptoms. Front Endocrinol (Lausanne). 2022;13:1034614.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1683_CR33","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.3390\/ijms24043809","volume":"24","author":"G Didziokaite","year":"2023","unstructured":"Didziokaite G, Biliute G, Gudaite J, Kvedariene V. Oxidative Stress as a Potential Underlying Cause of Minimal and Mild Endometriosis-Related Infertility. Int J Mol Sci. 2023;24(4):3809.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1683_CR34","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41574-019-0245-z","volume":"15","author":"C Chapron","year":"2019","unstructured":"Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):666\u201382.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1683_CR35","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/cdd.2014.157","volume":"22","author":"L Bakiri","year":"2015","unstructured":"Bakiri L, Macho-Maschler S, Custic I, Niemiec J, Gu\u00edo-Carri\u00f3n A, Hasenfuss SC, Eger A, M\u00fcller M, Beug H, Wagner EF. Fra-1\/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1\/2 and TGF\u03b2 expression. Cell Death Differ. 2015;22(2):336\u201350.","journal-title":"Cell Death Differ"},{"issue":"5","key":"1683_CR36","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3390\/cells10051253","volume":"10","author":"T Srivastava","year":"2021","unstructured":"Srivastava T, Heruth DP, Duncan RS, Rezaiekhaligh MH, Garola RE, Priya L, Zhou J, Boinpelly VC, Novak J, Ali MF, et al. Transcription factor beta-catenin plays a key role in fluid flow shear stress-mediated glomerular injury in solitary kidney. Cells. 2021;10(5):1253.","journal-title":"Cells"},{"issue":"684","key":"1683_CR37","doi-asserted-by":"publisher","first-page":"eabq5858","DOI":"10.1126\/scitranslmed.abq5858","volume":"15","author":"A Nishimoto-Kakiuchi","year":"2023","unstructured":"Nishimoto-Kakiuchi A, Sato I, Nakano K, Ohmori H, Kayukawa Y, Tanimura H, Yamamoto S, Sakamoto Y, Nakamura G, Maeda A, et al. A long-acting anti-IL-8 antibody improves inflammation and fibrosis in endometriosis. Sci Transl Med. 2023;15(684):eabq5858.","journal-title":"Sci Transl Med"},{"issue":"19","key":"1683_CR38","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.3390\/ijms221910498","volume":"22","author":"G Brichant","year":"2021","unstructured":"Brichant G, Laraki I, Henry L, Munaut C, Nisolle M. New therapeutics in endometriosis: a review of hormonal, non-hormonal, and non-coding RNA treatments. Int J Mol Sci. 2021;22(19):10498.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1683_CR39","doi-asserted-by":"publisher","first-page":"8035","DOI":"10.1111\/jcmm.14668","volume":"23","author":"W Xiong","year":"2019","unstructured":"Xiong W, Zhang L, Liu H, Li N, Du Y, He H, Zhang Z, Liu Y. E(2) -mediated EMT by activation of beta-catenin\/Snail signalling during the development of ovarian endometriosis. J Cell Mol Med. 2019;23(12):8035\u201345.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1683_CR40","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/jcm9061915","volume":"9","author":"L Konrad","year":"2020","unstructured":"Konrad L, Dietze R, Riaz MA, Scheiner-Bobis G, Behnke J, Horn\u00e9 F, Hoerscher A, Reising C, Meinhold-Heerlein I. Epithelial-mesenchymal transition in endometriosis-when does it happen? J Clin Med. 2020;9(6):1915.","journal-title":"J Clin Med"},{"key":"1683_CR41","doi-asserted-by":"publisher","first-page":"749979","DOI":"10.3389\/fimmu.2021.749979","volume":"12","author":"X Guo","year":"2021","unstructured":"Guo X, Xu X, Li T, Yu Q, Wang J, Chen Y, Ding S, Zhu L, Zou G, Zhang X. NLRP3 inflammasome activation of mast cells by estrogen via the nuclear-initiated signaling pathway contributes to the development of endometriosis. Front Immunol. 2021;12:749979.","journal-title":"Front Immunol"},{"issue":"4","key":"1683_CR42","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/biolre\/ioy242","volume":"100","author":"UK Soni","year":"2019","unstructured":"Soni UK, Chadchan SB, Kumar V, Ubba V, Khan MTA, Vinod BSV, Konwar R, Bora HK, Rath SK, Sharma S, et al. A high level of TGF-B1 promotes endometriosis development via cell migration, adhesiveness, colonization, and invasivenessdagger. Biol Reprod. 2019;100(4):917\u201338.","journal-title":"Biol Reprod"},{"key":"1683_CR43","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.gene.2017.11.010","volume":"644","author":"Z Xu","year":"2018","unstructured":"Xu Z, Zhao C, Wang Z, Tao J, Han Z, Zhang W, Tan R, Gu M. Interleukin-33 levels are elevated in chronic allograft dysfunction of kidney transplant recipients and promotes epithelial to mesenchymal transition of human kidney (HK-2) cells. Gene. 2018;644:113\u201321.","journal-title":"Gene"},{"key":"1683_CR44","first-page":"10","volume":"2019","author":"T Kato","year":"2021","unstructured":"Kato T, Yasuda K, Matsushita K, Ishii KJ, Hirota S, Yoshimoto T, Shibahara H. Interleukin-1\/-33 Signaling Pathways as Therapeutic Targets for Endometriosis. Front Immunol. 2021;2019:10.","journal-title":"Front Immunol"},{"issue":"7","key":"1683_CR45","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41388-022-02575-5","volume":"42","author":"JW Kwon","year":"2023","unstructured":"Kwon JW, Seok SH, Kim S, An HW, Choudhury AD, Woo SH, Oh JS, Kim JK, Voon DC, Kim DY, et al. A synergistic partnership between IL-33\/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis. Oncogene. 2023;42(7):501\u201315.","journal-title":"Oncogene"},{"issue":"5","key":"1683_CR46","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3390\/cells10051048","volume":"10","author":"O Pivovarova-Ramich","year":"2021","unstructured":"Pivovarova-Ramich O, Loske J, Hornemann S, Markova M, Seebeck N, Rosenthal A, Klauschen F, Castro J, Buschow R, Grune T, et al. Hepatic Wnt1 Inducible signaling pathway protein 1 (WISP-1\/CCN4) associates with markers of liver fibrosis in severe obesity. Cells. 2021;10(5):1048.","journal-title":"Cells"},{"issue":"4","key":"1683_CR47","first-page":"772","volume":"119","author":"M K\u00f6nigshoff","year":"2009","unstructured":"K\u00f6nigshoff M, Kramer M, Balsara N, Wilhelm J, Amarie OV, Jahn A, Rose F, Fink L, Seeger W, Schaefer L, et al. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest. 2009;119(4):772\u201387.","journal-title":"J Clin Invest"},{"issue":"11","key":"1683_CR48","doi-asserted-by":"publisher","first-page":"14507","DOI":"10.1096\/fj.202000953R","volume":"34","author":"B Wang","year":"2020","unstructured":"Wang B, Ding X, Ding C, Tesch G, Zheng J, Tian P, Ricardo S, Shen H-H, Xue W. WNT1-inducible-signaling pathway protein 1 regulates the development of kidney fibrosis through the TGF-\u03b21 pathway. FASEB J. 2020;34(11):14507\u201320.","journal-title":"FASEB J"},{"issue":"6","key":"1683_CR49","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.3390\/cancers14061480","volume":"14","author":"L Casalino","year":"2022","unstructured":"Casalino L, Talotta F, Cimmino A, Verde P. The Fra-1\/AP-1 Oncoprotein: From the \u201cUndruggable\u201d transcription factor to therapeutic targeting. Cancers (Basel). 2022;14(6):1480.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1683_CR50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.immuni.2021.12.001","volume":"55","author":"D He","year":"2022","unstructured":"He D, Xu H, Zhang H, Tang R, Lan Y, Xing R, Li S, Christian E, Hou Y, Lorello P, et al. Disruption of the IL-33-ST2-AKT signaling axis impairs neurodevelopment by inhibiting microglial metabolic adaptation and phagocytic function. Immunity. 2022;55(1):159-173 e159.","journal-title":"Immunity"},{"issue":"11","key":"1683_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00971","volume":"4","author":"T Nishizaki","year":"2018","unstructured":"Nishizaki T. IL-33 suppresses GSK-3beta activation through an ST2-independent MyD88\/TRAF6\/RIP\/PI3K\/Akt pathway. Heliyon. 2018;4(11): e00971.","journal-title":"Heliyon"},{"issue":"2","key":"1683_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41419-017-0226-x","volume":"9","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Zhou C, Yu XX, Wu C, Jia HL, Gao XM, Yang JM, Wang CQ, Luo Q, Zhu Y, et al. Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of \u03b2-Catenin. Cell Death Dis. 2018;9(2):179.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1683_CR53","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","volume":"42","author":"AB Molofsky","year":"2015","unstructured":"Molofsky AB, Savage AK, Locksley RM. Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. Immunity. 2015;42(6):1005\u201319.","journal-title":"Immunity"},{"key":"1683_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","volume":"40","author":"GK Dwyer","year":"2022","unstructured":"Dwyer GK, D\u2019Cruz LM, Turnquist HR. Emerging Functions of IL-33 in Homeostasis and Immunity. Annu Rev Immunol. 2022;40:15\u201343.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"1683_CR55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16(11):676\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1683_CR56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard JP. Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev. 2018;281(1):154\u201368.","journal-title":"Immunol Rev"},{"issue":"1","key":"1683_CR57","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jaci.2023.02.026","volume":"152","author":"A Holgado","year":"2023","unstructured":"Holgado A, Liu Z, Aidarova A, Mueller C, Haegman M, Driege Y, Kreike M, Scott CL, Afonina IS, Beyaert R. A20 is a master switch of IL-33 signaling in macrophages and determines IL-33-induced lung immunity. J Allergy Clin Immunol. 2023;152(1):244-256.e244.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1683_CR58","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/j.immuni.2021.09.010","volume":"54","author":"M Faas","year":"2021","unstructured":"Faas M, Ipseiz N, Ackermann J, Culemann S, Gr\u00fcneboom A, Schr\u00f6der F, Rothe T, Scholtysek C, Eberhardt M, B\u00f6ttcher M, et al. IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation. Immunity. 2021;54(11):2531-2546.e2535.","journal-title":"Immunity"},{"issue":"6501","key":"1683_CR59","doi-asserted-by":"publisher","first-page":"eaay1813","DOI":"10.1126\/science.aay1813","volume":"369","author":"S Taniguchi","year":"2020","unstructured":"Taniguchi S, Elhance A, Van Duzer A, Kumar S, Leitenberger JJ, Oshimori N. Tumor-initiating cells establish an IL-33-TGF-\u03b2 niche signaling loop to promote cancer progression. Science. 2020;369(6501):eaay1813.","journal-title":"Science"},{"issue":"6","key":"1683_CR60","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.1111\/aji.12836","volume":"79","author":"YR Sheng","year":"2018","unstructured":"Sheng YR, Hu WT, Wei CY, Tang LL, Liu YK, Liu YY, Qiu JP, Li DJ, Zhu XY. IL-33\/ST2 axis affects the polarization and efferocytosis of decidual macrophages in early pregnancy. Am J Reprod Immunol. 2018;79(6):e12836.","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"1683_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00018-022-04197-2","volume":"79","author":"YR Sheng","year":"2022","unstructured":"Sheng YR, Hu WT, Shen HH, Wei CY, Liu YK, Ma XQ, Li MQ, Zhu XY. An imbalance of the IL-33\/ST2-AXL-efferocytosis axis induces pregnancy loss through metabolic reprogramming of decidual macrophages. Cell Mol Life Sci. 2022;79(3):173.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"1683_CR62","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41419-023-06182-4","volume":"14","author":"Q Wu","year":"2023","unstructured":"Wu Q, Liang Z, Jiang J, Feng X, Liu J, Zhang Z, Wang H, Wang N, Gou Y, Li Z, et al. Macrophages originated IL-33\/ST2 inhibits ferroptosis in endometriosis via the ATF3\/SLC7A11 axis. Cell Death Dis. 2023;14(10):668.","journal-title":"Cell Death Dis"},{"issue":"12","key":"1683_CR63","doi-asserted-by":"publisher","first-page":"e156876","DOI":"10.1172\/JCI156876","volume":"132","author":"S Ryu","year":"2022","unstructured":"Ryu S, Shin JW, Kwon S, Lee J, Kim YC, Bae Y-S, Bae Y-S, Kim DK, Kim YS, Yang SH, et al. Siglec-F-expressing neutrophils are essential for creating a profibrotic microenvironment in renal fibrosis. J Clin Invest. 2022;132(12):e156876.","journal-title":"J Clin Invest"},{"issue":"4","key":"1683_CR64","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jhep.2023.05.045","volume":"79","author":"S Ari\u00f1o","year":"2023","unstructured":"Ari\u00f1o S, Aguilar-Bravo B, Coll M, Lee WY, Peiseler M, Cantallops-Vil\u00e0 P, Sererols-Vi\u00f1as L, Mart\u00ednez-Garc\u00eda de la Torre RA, Mart\u00ednez-S\u00e1nchez C, Pedragosa J, et al. Ductular reaction-associated neutrophils promote biliary epithelium proliferation in chronic liver disease. J Hepatol. 2023;79(4):1025\u201336.","journal-title":"J Hepatol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01683-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01683-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01683-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T01:02:37Z","timestamp":1717981357000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01683-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1683"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01683-x","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,10]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Obstetrics and Gynecology Hospital of Fudan University (2020\u2013137). All participants provided written informed consent to obtain the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}